Vaccine formulation

Details Vaccine formulation Vaccine formulation

1986-04-18

1989-02-21

Thexton, Matthew A.

Drug, bio-affecting and body treating compositions

Lymphokine

424 92, 514885, 514937, 514943, A61K 3900

Patent

active

048063509

ABSTRACT:
A highly immunogenic aqueous vaccine formulation adjuvanted with a saponin and an oil.

REFERENCES:
patent: 4101652 (1978-07-01), Bonati
Egerton et al., "Effect of Quil A . . . ", Vet. Sci. Communic. 2(1978) 247-252.
Scott, et al., "Adjuvant . . . Glycoprotein", Int. Archs Allergy Appl. Immun. 74: 373-377 (1984).
Maharaj, et al., "Immune Responses . . . Saponin", Can. J. Microbiol. vol. 32, 1986.
McColm, et al., "Comparison of Saponin . . . ", Parasite Immunol. 1982 4, 337-347.
Freund, Adv. Tuberc. Res. 7:130 (1956).
Dalsgaard et al., Acta vet. Scand. 18:349-360 (1977).
Bomford, Int. Arch. Allergy Appl. Immunol. 67(2): 127-131 (1982).
Charlier, et al., Arch. Exp. Vet.-Med. 27:783 (1973).

Affiliated with

Also associated with

Rating

Vaccine formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1521045